Status: Under consideration by AWMSG Scrutiny Panel | |
For the off-label treatment of Immune Checkpoint Inhibitor (ICI) induced grade 3-4 myocarditis that has not responded to first line immunosuppression with corticosteroids. |
|
Medicine details |
|
Medicine name | infliximab |
Formulation | powder for solution for infusion |
Reference number | 6460 |
Indication | As above |
Company | various |
BNF chapter | Malignant disease & immunosuppression |
Status | Under consideration by AWMSG Scrutiny Panel |
Scrutiny Panel meeting date | 06/03/2025 |